Adam Howard, DPM
Podiatry · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 35
- 10 carriers
- Office
- 1
Offices
1 location · Bay Area Foot Care Inc · 127 clinicians in this group
Looking this up.
Plans that list them
35 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Howard’s office at (408) 358-6234 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
35 of 35 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Surgery centers they own
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA.9 owner since 2011 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA.9 owner since 2011 · accredited by AAAHCAccreditation RenewedNo inspections published
Original Medicare doctor bills
$117,251
Medicare paid this office $117,251 for 276 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 204 | $44,955 | $78 |
| Removal of noncancer thickened skin growth, 2-4 growths | 76 | $18,731 | $75 |
| Return visit (30+ min) | 53 | $12,438 | $117 |
| New patient visit (30+ min) | 69 | $6,179 | $90 |
| Removal of fingernails or toenails, 6 or more nails | 69 | $5,553 | $38 |
See all 11 services
| Short return visit (20+ min) | 204 | $44,955 | $78 |
| Removal of noncancer thickened skin growth, 2-4 growths | 76 | $18,731 | $75 |
| Return visit (30+ min) | 53 | $12,438 | $117 |
| New patient visit (30+ min) | 69 | $6,179 | $90 |
| Removal of fingernails or toenails, 6 or more nails | 69 | $5,553 | $38 |
| New patient visit (45+ min) | 28 | $3,787 | $135 |
| Test or measurement for functional capacity, each 15 minutes | 56 | $3,086 | $28 |
| X-ray of foot, minimum of 3 views | 47 | $2,273 | $32 |
| Injection of anesthetic and/or steroid drug into foot nerve | 15 | $1,151 | $46 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $15 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $3 | None |
Procedures Medicare counted
| Removal of nail tissue | 250 | More than 76% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 224 | More than 92% of doctors who do this |
| Removal or shaving of skin growth | 249 | More than 91% of doctors who do this |
Who their Medicare patients are
276 Original Medicare patients in 2024. Average age 79 · Women 62% · Health risk score 1.07. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Coronary heart disease 28% · Diabetes 26% · Cancer 21% · Chronic kidney disease 17% · Atrial fibrillation 15% · Heart failure 13% · Depression 12% · Dementia 10% · COPD 8% · Stroke 8%.
The office billed $512,905, Medicare allowed $162,771 and paid $117,251; for 1,710 services of 54 kinds; $19 of it was for drugs given in the office and $117,232 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 276 | 1,710 | 79 | 1.07 | $512,905 | $117,251 |
| 2023 | 244 | 1,687 | 78 | 0.91 | $487,331 | $116,432 |
| 2022 | 210 | 1,343 | 78 | 0.99 | $326,362 | $93,444 |
| 2021 | 180 | 1,114 | 77 | 1.01 | $153,278 | $85,000 |
| 2020 | 190 | 964 | 78 | 1.21 | $125,178 | $66,419 |
| 2019 | 212 | 1,118 | 77 | 1.08 | $150,458 | $79,841 |
| 2018 | 152 | 884 | 77 | 1.19 | $123,464 | $47,372 |
| 2017 | 142 | 829 | 78 | 1.10 | $86,969 | $36,132 |
| 2016 | 132 | 765 | 79 | 1.02 | $82,507 | $34,870 |
| 2015 | 154 | 780 | 77 | 1.05 | $79,534 | $36,343 |
| 2014 | 161 | 778 | 78 | 1.16 | $80,429 | $39,180 |
| 2013 | 144 | 752 | 77 | 1.14 | $90,748 | $42,838 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 180 | $49,573 | $80 |
| Removal of noncancer thickened skin growth, 2-4 growths | 73 | $18,616 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 67 | $8,896 | $42 |
| New patient visit (30+ min) | 68 | $6,448 | $95 |
| Return visit (30+ min) | 28 | $6,238 | $122 |
| X-ray of foot, minimum of 3 views | 45 | $2,821 | $36 |
| Injection of anesthetic and/or steroid drug into foot nerve | 16 | $1,095 | $46 |
| Aspiration and/or injection of fluid from medium joint | 14 | $803 | $47 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $24 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 17 | $18 | None |
2022: 10 services
| Short return visit (20+ min) | 147 | $38,881 | $77 |
| Removal of noncancer thickened skin growth, 2-4 growths | 76 | $15,900 | $74 |
| Removal of fingernails or toenails, 6 or more nails | 76 | $8,577 | $38 |
| New patient visit (30+ min) | 51 | $3,887 | $76 |
| X-ray of foot, minimum of 3 views | 44 | $2,880 | $33 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 19 | $2,771 | $81 |
| Return visit (30+ min) | 19 | $2,439 | $116 |
| Injection of anesthetic and/or steroid drug into foot nerve | 17 | $878 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $21 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 14 | $3 | None |
2021: 5 services
| Short return visit (20+ min) | 124 | $35,357 | $82 |
| Removal of noncancer thickened skin growth, 2-4 growths | 67 | $17,841 | $80 |
| Removal of fingernails or toenails, 6 or more nails | 66 | $9,218 | $42 |
| New patient visit (30+ min) | 41 | $3,705 | $90 |
| X-ray of foot, minimum of 3 views | 35 | $2,093 | $32 |
2020: 6 services
| Short return visit (20+ min) | 117 | $22,948 | $66 |
| Removal of noncancer thickened skin growth, 2-4 growths | 75 | $15,434 | $70 |
| Removal of fingernails or toenails, 6 or more nails | 64 | $7,952 | $43 |
| New patient visit (30+ min) | 49 | $3,846 | $78 |
| Return visit (30+ min) | 18 | $2,666 | $92 |
| X-ray of foot, minimum of 3 views | 31 | $1,487 | $30 |
2019: 8 services
| Short return visit (20+ min) | 134 | $27,500 | $68 |
| Removal of noncancer thickened skin growth, 2-4 growths | 86 | $14,370 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 68 | $8,340 | $41 |
| New patient visit (30+ min) | 70 | $6,153 | $88 |
| Return visit (30+ min) | 34 | $5,554 | $101 |
| New patient visit (45+ min) | 13 | $1,986 | $153 |
| Simple separation of fingernail or toenail from nail bed, first nail | 16 | $1,786 | $105 |
| X-ray of foot, minimum of 3 views | 27 | $1,237 | $30 |
2018: 8 services
| Short return visit (20+ min) | 93 | $14,515 | $59 |
| Removal of noncancer thickened skin growth, 2-4 growths | 55 | $7,491 | $48 |
| Removal of fingernails or toenails, 6 or more nails | 55 | $5,309 | $37 |
| New patient visit (30+ min) | 47 | $3,946 | $84 |
| Return visit (30+ min) | 18 | $2,239 | $90 |
| X-ray of foot, minimum of 3 views | 23 | $1,020 | $26 |
| Trimming of dystrophic nails, any number | 15 | $560 | $12 |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $5 | None |
2017: 9 services
| Short return visit (20+ min) | 83 | $12,808 | $60 |
| Removal of noncancer thickened skin growth, 2-4 growths | 52 | $7,185 | $47 |
| Removal of fingernails or toenails, 6 or more nails | 39 | $4,097 | $35 |
| New patient visit (30+ min) | 46 | $3,752 | $82 |
| Trimming of dystrophic nails, any number | 17 | $715 | $12 |
| X-ray of foot, minimum of 3 views | 15 | $711 | $25 |
| Aspiration and/or injection of fluid from medium joint | 12 | $616 | $34 |
| Injection, methylprednisolone acetate, 40 mg | 15 | $136 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 16 | $7 | None |
2016: 5 services
| Short return visit (20+ min) | 61 | $8,876 | $62 |
| Removal of noncancer thickened skin growth, 2-4 growths | 68 | $8,146 | $48 |
| Removal of fingernails or toenails, 6 or more nails | 45 | $5,430 | $36 |
| New patient visit (30+ min) | 43 | $3,764 | $88 |
| Trimming of dystrophic nails, any number | 21 | $947 | $12 |
2015: 9 services
| Short return visit (20+ min) | 67 | $9,382 | $63 |
| Removal of fingernails or toenails, 6 or more nails | 63 | $6,795 | $38 |
| Removal of noncancer thickened skin growth, 2-4 growths | 52 | $5,624 | $52 |
| New patient visit (30+ min) | 41 | $3,313 | $81 |
| Permanent removal fingernail or toenail | 12 | $2,989 | $187 |
| Trimming of dystrophic nails, any number | 29 | $1,419 | $15 |
| Removal of fingernails or toenails, 1-5 nails | 18 | $862 | $29 |
| Removal of noncancer thickened skin growth, 1 growth | 14 | $773 | $43 |
| Injection, dexamethasone sodium phosphate, 1 mg | 11 | $4 | None |
2014: 9 services
| Short return visit (20+ min) | 68 | $9,150 | $62 |
| Removal of fingernails or toenails, 6 or more nails | 64 | $6,996 | $38 |
| Removal of noncancer thickened skin growth, 2-4 growths | 40 | $5,225 | $49 |
| New patient visit (30+ min) | 52 | $4,360 | $84 |
| Trimming of dystrophic nails, any number | 29 | $1,623 | $17 |
| X-ray of foot, minimum of 3 views | 22 | $1,005 | $30 |
| Removal of noncancer thickened skin growth, 1 growth | 19 | $918 | $42 |
| Short return visit | 13 | $581 | $42 |
| Removal of fingernails or toenails, 1-5 nails | 15 | $516 | $29 |
2013: 8 services
| Short return visit (20+ min) | 59 | $6,960 | $65 |
| Removal of noncancer thickened skin growth, 2-4 growths | 48 | $6,601 | $52 |
| Removal of fingernails or toenails, 6 or more nails | 54 | $6,380 | $40 |
| New patient visit (30+ min) | 55 | $4,977 | $90 |
| Return visit (30+ min) | 18 | $2,284 | $95 |
| Trimming of dystrophic nails, any number | 31 | $1,761 | $17 |
| X-ray of foot, minimum of 3 views | 22 | $1,258 | $31 |
| Removal of noncancer thickened skin growth, 1 growth | 15 | $719 | $42 |
Drugs they prescribed that Part D paid
$577
Pharmacies billed $577 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
51 generic and 0 brand-name prescriptions · $577 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Meloxicam | 11 | $33 | $1 |
Year by year
| 2024 | 51 | 22 | None | 0% | $577 |
| 2023 | 22 | 11 | None | 0% | $231 |
| 2022 | 26 | 12 | 46% (12) | 0% | $311 |
| 2021 | 27 | 17 | 56% (15) | None | $1,179 |
| 2020 | 28 | 15 | 54% (15) | 0% | $675 |
| 2019 | 19 | 15 | None | 0% | $671 |
| 2014 | 17 | None | None | 0% | $568 |
| 2013 | 13 | None | None | None | $882 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$734 in 2025
| 2025 | 9 | 13 | None | $734 |
| 2024 | 6 | 8 | None | $333 |
| 2023 | 10 | 19 | None | $839 |
| 2022 | 6 | 13 | None | $800 |
| 2021 | 6 | 12 | None | $317 |
| 2020 | 10 | 20 | None | $831 |
| 2019 | 13 | 44 | None | $1,570 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Krystexxa | $295 | 4 payments
|
| Stryker | Ortholoc 2 Lapifuse | $140 | 1 payment
|
| Smith+Nephew | Grafix | $125 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $54 | 2 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $31 | 1 payment
|
| MIMEDX Group | None | $27 | 1 payment
|
See all 13 published payments
| Access Pro Medical | Meals · 2025-12-09 | Matriderm | $27 |
| Bioventus | Meals · 2025-12-05 | Exogen Ultrasound Bone Healing System | $31 |
| Orthofix Medical | Meals · 2025-11-14 | Physio-Stim | $18 |
| Amgen | Meals · 2025-11-06 | Krystexxa | $23 |
| Treace Medical Concepts | Meals · 2025-10-23 | Tmc Nanoplasty System | $16 |
| Stryker | Meals · 2025-09-12 | Ortholoc 2 Lapifuse | $140 |
| Paratek Pharmaceuticals | Meals · 2025-08-07 | Nuzyra | $32 |
| Amgen | Meals · 2025-07-31 | Krystexxa | $122 |
| Paratek Pharmaceuticals | Meals · 2025-07-07 | Nuzyra | $22 |
| MIMEDX Group | Meals · 2025-06-10 | None | $27 |
| Smith+Nephew | Meals · 2025-05-07 | Grafix | $125 |
| Amgen | Meals · 2025-04-24 | Krystexxa | $25 |
| Amgen | Meals · 2025-04-08 | Krystexxa | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $333
| Alafair Biosciences | Versawrap | $149 | 1 payment
|
| Biotissue Holdings | None | $69 | 2 payments
|
| Amgen | Krystexxa | $43 | 2 payments
|
| Averitas Pharma | Qutenza | $29 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $26 | 1 payment
|
| Stryker | Prostep Mica | $17 | 1 payment
|
2023: $839
| Nevro | Senza | $194 | 3 payments
|
| Linvatec | Fracture and Correction Colag 2 | $171 | 2 payments
|
| Organogenesis | Puraply | $125 | 1 payment
|
| Biotissue Holdings | Neox | $95 | 4 payments
|
| Paragon 28 | Mtp | $79 | 1 payment
|
| Averitas Pharma | Qutenza | $63 | 3 payments
|
| Stryker | Prostep | $35 | 1 payment
|
| Zimmer Biomet Holdings | Tapestry | $34 | 2 payments
|
| Smith+Nephew | Stravix Pl | $25 | 1 payment
|
| Ossio | None | $20 | 1 payment
|
2022: $800
| Smith+Nephew | Grafix Pl | $303 | 4 payments
|
| Zimmer Biomet Holdings | Ventix | $183 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $156 | 4 payments
|
| BioTissue Holdings | Neox | $121 | 1 payment
|
| Paragon 28 | Tenotac | $21 | 1 payment
|
| GRT US Holding | Qutenza | $15 | 1 payment
|
2021: $317
| Organogenesis | Affinity | $125 | 1 payment
|
| Smith+Nephew | Grafix Pl | $113 | 7 payments
|
| Alfasigma USA | None | $24 | 1 payment
|
| Gramercy Extremity Orthopedics | None | $21 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $19 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $15 | 1 payment
|
2020: $831
| Musculoskeletal Transplant Foundation | None | $220 | 1 payment
|
| Smith+Nephew | Grafix Pl | $191 | 8 payments
|
| Zimmer Biomet Holdings | Stratum Foot Plating System | $107 | 1 payment
|
| Wright Medical Technology | Ortholoc | $100 | 1 payment
|
| Integra LifeSciences | Salto Talaris Total Ankle Prosthesis | $74 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $47 | 2 payments
|
| Acell | None | $30 | 1 payment
|
| Amniox Medical | Neox | $25 | 1 payment
|
| Fidia Pharma USA | Nudyn | $24 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $13 | 1 payment
|
2019: $1,570
| Integra LifeSciences | Salto Talaris Total Ankle Prosthesis | $469 | 11 payments
|
| Medical Device Business Services | VA-Lcp Plates & Screws | $339 | 4 payments
|
| Smith+Nephew | Grafix Pl Prime | $187 | 7 payments
|
| Horizon Therapeutics plc | Krystexxa | $118 | 6 payments
|
| DePuy Synthes Sales | Bme Nitinol Continuous Compression Implants | $114 | 2 payments
|
| Osiris Therapeutics | Stravix | $100 | 2 payments
|
| Arthrosurface | Hemicap Mtp Resurfacing | $59 | 3 payments
|
| Evolution Surgical | None | $56 | 1 payment
|
| Fidia Pharma USA | Nudyn | $38 | 3 payments
|
| Wright Medical Technology | Phalinx | $31 | 2 payments
|
| Paragon 28 | None | $20 | 1 payment
|
| Zimmer Biomet Holdings | Biomet Orthopak | $20 | 1 payment
|
| Zyla Life Sciences | Zorvolex | $20 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 75.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Patients can see their records onlinePatients who were given electronic access to their health information | 98%That's most of the people this applied to. | 899 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from e-prescribing
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1679712624
- Licence
- CA E4816
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X); Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 10353 Torre Ave, Suite C, Cupertino, CA, 95014
- NPI first listed
- 2009-02-16
- NPI last updated
- 2026-08-18
- NPI record certified
- 2026-08-18
This is when the NPI record was last certified, not a medical board exam.